Grifols (GIFLF) Assets Growth (3y) (2012 - 2025)
Powered by 
Analysis
Grifols (GIFLF) Assets Growth (3y) (2012 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.94% |
| Dec 31, 2024 | 39.81% |
| Dec 31, 2023 | 7.44% |
| Dec 31, 2022 | 7.98% |
| Dec 31, 2021 | -16.23% |
| Dec 31, 2020 | 12.30% |
| Dec 31, 2019 | 16.30% |
| Sep 30, 2019 | 13.51% |
| Mar 31, 2019 | 14.30% |
| Dec 31, 2018 | 10.61% |
| Sep 30, 2018 | 10.30% |
| Mar 31, 2018 | 15.80% |
| Dec 31, 2017 | 6.78% |
| Jun 30, 2017 | 6.99% |
| Dec 31, 2016 | 11.22% |
| Sep 30, 2016 | 12.17% |
| Jun 30, 2016 | 12.19% |
| Mar 31, 2016 | 10.09% |
| Dec 31, 2015 | 12.98% |
| Sep 30, 2015 | 11.83% |